Ypsomed’s CliniPilot is an innovative add-on technology available in two versions, for YpsoMate 1 mL and 2.25 mL autoinjectors, transforming them into smart, connected devices, enabling connected clinical trials. It automatically captures and securely transmits key injection data—including time, date, injection outcome, and any identified user errors that may occur—via Bluetooth to a companion app. The app formats the data to be fully compatible with major Electronic Data Capture (EDC) systems and transmits it, ensuring that pharmaceutical partners retain full ownership of the data. Seamlessly embedded in current workflows, CliniPilot supports pre-approval trials and post-approval RWE programs across traditional, hybrid, and fully decentralized models. Developed in line with regulatory guidance without the need for regulatory clearance—enhancing flexibility, efficiency, and scalability.
Dimensions and specifications Facts and figures
Device specifications
- DimensionFor YpsoMate® 2.25: 5.3 × 1.6 × 1.6 inches or 134.5 × 39.6 × 40.4 mm
For YpsoMate® 1.0: 6.1 × 1.4 × 1.4 inches or 153.8 × 36.0 × 35.2 mm
- WeightFor YpsoMate® 2.25: 61 g or 0.13 lb
For YpsoMate® 1.0: 53 g or 0.12 Ib
- TypeHandheld, reusable, non-rechargeable
- Environmental conditions41 °F to 95 °F or + 5 °C to + 35 °C @ 15–90 % rH non-condensing within the atmospheric pressure range 700–1060 hPa
- Ingress protection calssificationIP 20 as defined by IEC 60529
- Intended usage lifetimeReusable without charging for up to 2 years or 120 injections after a storage period of up to 3 years
- Data loggingSecured data storage for the captured injection data and device data
- Feedback (User interface)*Real-time patient guidance using acoustic and visual feedback
- CommunicationBluetooth® for the data transmission and the NFC for the pairing
- Data securityTLS 1.3 end-to-end secured communication, sensitive data end-to-end ECIES encrypted
- Smart NFC-based label*ISO 15693-compliant NFC reader for the SmartLabel of the YpsoMate®
- Sensors and detection capabilitiesAutomated activation of the device with motion sensing.
Detection of autoinjector presence.
Inductive coupling detection of the injection status.